C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia

Table 4

Baseline characteristics of ARVD/C patients with or without documented VT.

	VT+ (𝑛=46) Mean ± SD	VT− (𝑛=14) Mean ± SD	𝑃 value
Age (years)	40 ± 15	38 ± 8	.641
Male (%)	87	79	.423
Hypertension (%)	11	0	.561
Hypercholesterolemia (%)	16	0	.313
Smokers (%)	14	27	.367
RV dysfunction (%)	24	21	.998
Statin (%)	7	0	.998
Aspirin (%)	4	0	.998
CRP level (mg/L)	3.6 ± 5.1	3.1 ± 4.1	.372

ARVD/C, Arrhythmogenic right ventricular dysplasia/cardiomyopathy; RVOT, Right ventricular outflow tract; RV, Right ventricular; VT, Ventricular tachycardia; VT-R, Ventricular tachycardia rate; ICD, Implantable cardioverter-defibrillator; CRP, C-reactive protein.